Conventional therapy with neutral phosphate and active vitamin D improves height in pre-pubertal children with XLH, but the efficacy on height improvement has no associations with sex, the dose of active vitamin D, and the variant types of the PHEX gene. Here, PHEX is linked to X-linked hypophosphatemia.